Australian veterinarians can now purchase our full range of products directly from Zoetis.
Zoetis Direct is a business-to-business initiative. Zoetis does not supply products directly to the general public.
VIDEO: OVERVIEW OF ZOETIS DIRECT
Zoetis Direct evolves the way we deliver value to you, your clinic and importantly to your patients. You will enjoy transparent pricing, a simple ordering system, seamless delivery and easy access to expert advice through our direct distribution commitment.
First and only product to provide twelve months of protection from heartworm infection in a single subcutaneous dose, due to its sustained release technology.
The single administration of ProHeart SR-12 eliminates the possibility of the pet owner missing one or more monthly dose, which is the primary cause of lack of efficacy associated with heartworm medications.
Efficacious and well tolerated in a variety of canine breeds.
ProHeart SR-12 exerts its effect at the tissue migrating stage by acting on the glutamate-gated chloride channel complex. This causes an influx of chloride ions and hyperpolarisation of cell membranes, resulting in paralysis and death of the parasitic organism. Another proposed mechanism of action for moxidectin is through enhancing release of GABA at presynaptic neurons. GABA acts as an inhibitory neurotransmitter.
After resuspending the product with sterile vehicle, administer 1 mL of suspension per 20 kg of body weight to provide a dose of 0.5 mg moxidectin/kg body weight. To maintain full protection, repeat dosing every 12 months.
Recommended for use in dogs from 12 weeks of age.
The following table may be used as a guide to dosage:
Dog Weight (kg)
Dose Volume (mL/dog)
Dogs over 65 kg receive 0.25 mL for each additional 5 kg body weight.